News | 30 September 2023
Advent International announces the completion of the acquision of Suven Pharma
New Board of Directors and management team at Suven Pharma also appointed
New Board of Directors and management team at Suven Pharma also appointed
The introduction of 'Definisse Core Filler' is a testament to the company's premium scientific-based innovation
The aggregate foreign investment, including investment from other foreign investors may be up to 90.1% shareholding in the company
Capital raise to accelerate product and technology development and support expansion efforts to reshape communications to HCPs across the globe
Post-acquisition of the balance 25% outstanding shares will result into Sun Pharma de México, S.A. de C.V. becoming a wholly-owned subsidiary of the company.
WINLEVI works differently from any other topical acne treatment
The first phase of the hospital with 225 beds built over 1.75 lakh square feet will be commissioned in the next 12 months
Education on Inhalation Therapy & Conducting Nationwide Awareness Camps, Alkem Breathe Initiative Addresses the Alarming Increase in Respiratory Diseases in India
‘Sanjeevani’ aims to raise awareness and encourage conversations around the silent cancer epidemic
The investment will help the company meet soaring demand for user-friendly oral dosage form development and manufacturing
Kivo’s expanded platform brings compliant collaboration and intelligent process automation to emerging Regulatory, Clinical and Quality teams
India is promoting holistic healthcare with emphasis on preventive care
Biosergen AB is developing BSG005 for the treatment of severe and difficult-to-treat invasive fungal diseases
Mankind Pharma commences the commercial operations newly set-up plant in Udaipur
Dr. Jitendra Singh inaugurates 300 LPM capacity Oxygen Plant, Day Care Chemotherapy Unit affiliated to Tata Memorial Hospital & Maternal ICU at GMC Kathua
The medical center at the Buddh International Circuit will be under the care of the Indraprastha Apollo Hospital team
Lupin has been exclusively marketing these brands in the Indian market since July 2021
Research released at UN General Assembly week shows tests predicting heart disease and diabetes are among lowest cost solutions for improving Indian health
Will continue to own a 7.84 per cent stake in Glenmark Life Sciences with the stake reduction
This production block consists of chemical synthesis reactions and clean rooms areas to produce final API
Subscribe To Our Newsletter & Stay Updated
